Kuaishou Stock Jumps on Kling AI IPO Plans and $20 Billion Valuation 
Trump and IRS in Settlement Talks Over $10 Billion Tax Return Leak Lawsuit 
The four types of dementia most people don’t know exist 
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship 
CSL Shares Crash as Profit Warning and $5 Billion Impairment Shake Investors 
Judge Rules DOGE Humanities Grant Cuts Unconstitutional 
Comey Faces Charges Over Instagram Post as Free Speech Debate Intensifies 
Arcadia Mayor Eileen Wang Pleads Guilty in China Foreign Agent Case 
Federal Appeals Court Allows Texas SB4 Immigration Law Enforcement to Proceed 
US Auto Industry Urges Trump to Block Chinese EV Market Access 
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment 
AcadeMedia Q3 Profit Climbs as International and Adult Education Segments Drive Growth 
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint 
Dell Stock Hits Record High After Trump Endorsement, AI Server Demand Fuels Rally 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit 
Why the future of marijuana legalization remains hazy despite high public support 
Rite Aid has sued the U.S. Department of Justice (DOJ) to halt a lawsuit alleging the company's involvement in illegally filling prescriptions for addictive opioid medications. The lawsuit comes as Rite Aid finds itself in a bankruptcy situation.
Reuters reported that the DOJ's position threatens to impede the ongoing restructuring efforts by the company. In response, Rite Aid has requested the U.S. Bankruptcy Judge Michael Kaplan will rule that the DOJ lawsuit should not proceed while the company is under bankruptcy protection.
DOJ's Lawsuit Pause and Rite Aid's Request for Equal Treatment
The DOJ had initially filed the lawsuit against Rite Aid in March, and despite Rite Aid's bankruptcy filing, it agreed to a "brief pause" of the lawsuit, according to PennLive. However, Rite Aid argues that this stance undermines its restructuring efforts.
Rite Aid seeks to put the government on equal footing with other opioid-related plaintiffs whose lawsuits were automatically halted due to the company's bankruptcy filing. The DOJ maintains that its lawsuit is not affected by the bankruptcy filing as it exercises its "police powers" through legal action.
Rite Aid, which operates approximately 2,000 retail pharmacies across 17 U.S. states, filed for bankruptcy protection in October. It aims to close underperforming stores and address over 1,600 lawsuits surrounding allegations of over-selling addictive opioid medications by filling illegal or suspicious prescriptions. However, a court-appointed committee representing opioid plaintiffs has expressed concerns over potential non-payment to victims harmed by Rite Aid's alleged reckless sale of opioid drugs.
Rite Aid's Legal Battle Implications
As Rite Aid fights the DOJ's lawsuit, the outcome will have far-reaching implications. It will determine whether the company can proceed with its restructuring efforts unhampered by legal actions, and if the DOJ's exercise of "police powers" can continue despite Rite Aid's bankruptcy status.
Additionally, the opioid creditors and victims affected by the company's alleged actions will closely monitor the proceedings, hoping for equitable resolutions.
Attorney Arik Preiss, representing opioid creditors, raised concerns that Rite Aid's bankruptcy proceedings seem to prioritize its top lenders over other stakeholders, potentially putting them at odds with the DOJ.
Rite Aid's major competitors, including Walgreens, Walmart, and CVS, have already agreed to settle a series of similar opioid lawsuits outside of bankruptcy, amounting to $13.8 billion.
The DOJ's opposition to opioid settlements in the bankruptcies of Endo International and Purdue Pharma has complicated those cases as well, delaying proposed settlements and drawing appeals to higher courts.
Photo: Rite Aid Newsroom
